Literature DB >> 25978200

Common questions about chronic low back pain.

Christopher M Herndon1, Kimberly Schiel Zoberi2, Bruce J Gardner3.   

Abstract

More than 30% of U.S. adults report having experienced low back pain within the preceding three months. Although most low back pain is nonspecific and self-limiting, a subset of patients develop chronic low back pain, defined as persistent symptoms for longer than three months. Low back pain is categorized as nonspecific low back pain without radiculopathy, low back pain with radicular symptoms, or secondary low back pain with a spinal cause. Imaging should be reserved for patients with red flags for cauda equina syndrome, recent trauma, risk of infection, or when warranted before treatment (e.g., surgical, interventional). Prompt recognition of cauda equina syndrome is critical. Patient education should be combined with evidence-guided pharmacologic therapy. Goals of therapy include reducing the severity of pain symptoms, pain interference, and disability, as well as maximizing activity. Validated tools such as the Oswestry Disability Index can help assess symptom severity and functional change in patients with chronic low back pain. Epidural steroid injections do not improve pain or disability in patients with spinal stenosis. Spinal manipulation therapy produces small benefits for up to six months. Because long-term data are lacking for spinal surgery, patient education about realistic outcome expectations is essential.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 25978200

Source DB:  PubMed          Journal:  Am Fam Physician        ISSN: 0002-838X            Impact factor:   3.292


  9 in total

1.  Short-term results of intrathecal injection of low-dose bupivacaine in outpatients with chronic low back and lower extremity pain.

Authors:  Akifumi Kanai; Takashi Okamoto; Norihito Hayashi; Junko Shimao; Yuki Nagahara; Kaoru Fujii
Journal:  Eur Spine J       Date:  2018-10-26       Impact factor: 3.134

2.  Ankylosing spondylitis diagnosis in US patients with back pain: identifying providers involved and factors associated with rheumatology referral delay.

Authors:  Atul Deodhar; Manish Mittal; Patrick Reilly; Yanjun Bao; Shivaji Manthena; Jaclyn Anderson; Avani Joshi
Journal:  Clin Rheumatol       Date:  2016-03-18       Impact factor: 2.980

3.  Effect of statin use on pain relief by transforaminal epidural steroid injection.

Authors:  Sinem Sari; Osman Nuri Aydın; Banu Tasdemir; Fabrizio Galimberti; Alparslan Turan
Journal:  J Int Med Res       Date:  2016-02-19       Impact factor: 1.671

4.  Interplay among pain intensity, sleep disturbance and emotion in patients with non-specific low back pain.

Authors:  Shilabant Sen Sribastav; He Peiheng; Long Jun; Li Zemin; Wei Fuxin; Wang Jianru; Liu Hui; Wang Hua; Zheng Zhaomin
Journal:  PeerJ       Date:  2017-05-16       Impact factor: 2.984

Review 5.  Application of machine learning in the diagnosis of axial spondyloarthritis.

Authors:  Jessica A Walsh; Martin Rozycki; Esther Yi; Yujin Park
Journal:  Curr Opin Rheumatol       Date:  2019-07       Impact factor: 5.006

6.  The relationship between the psychological stress of adolescents in school and the prevalence of chronic low back pain: a cross-sectional study in China.

Authors:  Qixiang Mei; Chunlin Li; Yue Yin; Qi Wang; Qiugen Wang; Guoying Deng
Journal:  Child Adolesc Psychiatry Ment Health       Date:  2019-06-17       Impact factor: 3.033

7.  Intramedullary Abscess by Staphylococcus aureus Presenting as Cauda Equina Syndrome to the Emergency Department.

Authors:  Dimitrios Damaskos; Helene Jumeau; François-Xavier Lens; Philippe Lechien
Journal:  Case Rep Emerg Med       Date:  2016-05-16

8.  Prediction of clinical outcomes in individuals with chronic low back pain: a protocol for a systematic review with meta-analysis.

Authors:  Liliane Mendonça; Matilde Monteiro-Soares; Luís Filipe Azevedo
Journal:  Syst Rev       Date:  2018-10-02

9.  Gua sha therapy for chronic low back pain: A protocol for systematic review.

Authors:  Yu-Wei Wang; Zhen-Wen Xi; Bin Pu; Guang-Yan Chen; Yu-Feng Ma; Ding-Long Liu; Xiao Xu
Journal:  Medicine (Baltimore)       Date:  2020-10-02       Impact factor: 1.817

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.